Publication | Open Access

Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma

OncologyMedicineColorectal CancerPathologyIrinotecan/5-fluorouracil/folinic AcidFirst-line TreatmentSafe CombinationCancer TreatmentPharmacologyRadiation Oncology